Facial Dysmorphism: An Unreported Teratogenicity with Levetiracetam

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 1

Abstract

Levetiracetam (LEV) is a relatively newer anticonvulsant drug used to treat epilepsy and is approved by United States Food and Drugs Administration (USFDA). The drug binds to a synaptic vesicle glycoprotein and inhibits presynaptic calcium channels, thus reducing neurotransmitter release. Commonly reported side effects include drowsiness, weakness, unsteady gait, mood changes and loss of appetite. Like most other antiepileptics, it is a Category C drug in pregnancy. We report the first case of facial dysmorphism in the neonate of a mother taking LEV antenatally. A 30-year-old lady, G2 P1 L1 presented at 38 weeks gestation with history of previous caesarean and leaking per vaginum. She was a known epileptic, taking carbamazepine since three to four years. She was switched over to LEV at fifth week of pregnancy. Her antenatal period was uneventful. Basic investigations including anomaly scan were normal. Unfavourable cervix necessitated caesarean section. Neonate (female) had dysmorphic facies with bilateral preauricular appendages and lateral cleft. Infantogram was suggestive of bifid vertebra in thoracic region. Computed Tomography (CT) scan chest revealed bifid vertebral body at D5 level with fusion of spinous process of D5 and D6 vertebra on left side. This is the first case of LEV induced facial dysmorphism, highlighting the need of further studies on LEV safety during pregnancy.

Authors and Affiliations

Jyotsana Gupta, Sandhya Jain, Shalini Rajaram, Neerja Goel, Bindiya Gupta

Keywords

Related Articles

Is Luteal Phase Estradiol Supplementation Beneficial in Long Agonist IVF-ET Cycles? First Prospective Randomised Controlled Study from Indian Subcontinent

ABSTRACT Introduction: The role of addition of estradiol to progesterone as luteal phase support in women undergoing In Vitro Fertilization (IVF) is not yet clear. Aim: To determine the efficacy of oral estradiol valer...

A Rare Familial Presentation of Facial Talon Cusp

Talon cusp is a rare developmental anomaly presenting as a wisp like structure arising from the cervical region of anterior teeth. They are predominantly seen in permanent dentition with a male predilection and are commo...

Salmonella Sepsis and Urinary Tract Infection Complicating with Acute Kidney Injury in a HIV Positive Female Patient

ABSTRACT Urinary Tract Infection (UTI) can rarely be caused by salmonella species. UTI salmonellosis may present as uncomplicated UTI, pyelonephritis or haemorrhagic cystitis. We present a case of a 44-year-old HIV posit...

A Comparative Analysis of Two Different Dose Fractionation Regimens of High Dose Rate Intracavitary Brachytherapy in Treatment of Carcinoma of Uterine Cervix: A Prospective Randomized Study

Introduction: High Dose Rate (HDR) intracavitary brachytherapy is an integral component in treatment of carcinoma uterine cervix. There is no consensus about optimal fractionation in HDR brachytherapy. Aim: To assess the...

Modelling the Health Economic Impact of Influenza Vaccination Strategies for High-Risk Children in Vietnam

ABSTRACT Introduction: In Vietnam, since 2011 a National Influenza Surveillance System in Vietnam has implemented Severe Acute Respiratory Infection (SARI) surveillance to assemble information and inform administrational...

Download PDF file
  • EP ID EP328447
  • DOI 10.7860/JCDR/2017/23824.9269
  • Views 169
  • Downloads 0

How To Cite

Jyotsana Gupta, Sandhya Jain, Shalini Rajaram, Neerja Goel, Bindiya Gupta (2017). Facial Dysmorphism: An Unreported Teratogenicity with Levetiracetam. Journal of Clinical and Diagnostic Research, 11(1), 8-9. https://www.europub.co.uk/articles/-A-328447